Provided by Tiger Trade Technology Pte. Ltd.

BAIYUNSHAN PH

15.070
-0.200-1.31%
Volume:628.00K
Turnover:9.46M
Market Cap:24.50B
PE:7.04
High:15.160
Open:15.110
Low:15.020
Close:15.270
52wk High:19.716
52wk Low:14.000
Shares:1.63B
HK Float Shares:219.90M
Volume Ratio:1.11
T/O Rate:0.29%
Dividend:0.96
Dividend Rate:6.34%
EPS(LYR):2.141
ROE:7.43%
ROA:2.37%
PB:0.53
PE(LYR):7.04
PS:0.27

Loading ...

白云山医药2025年收入达人民币77,656,109,939.23元,归母净利同比增长5.21%

Bulletin Express
·
Apr 22

Baiyunshan PH Adopts Full Electronic Dissemination of Corporate Communications

Bulletin Express
·
Apr 22

Baiyunshan Pharmaceutical Sets 27 April 2026 Board Meeting to Review Q1 2026 Unaudited Results

Bulletin Express
·
Apr 14

Revenue Growth Masks Cash Flow Crisis: Baiyunshan Faces Three Structural Risks

Deep News
·
Apr 03

JPMorgan Increases Stake in Baiyunshan by Approximately 143,900 Shares at HK$16.89 Per Share

Stock News
·
Apr 02

Baiyunshan Pharma Gets Approval for Carbocisteine Oral Solution's Registration in Macau

MT Newswires Live
·
Apr 02

Baiyunshan Pharmaceutical Gets Nod for Marketing Transfer of Bone Health Drug

MT Newswires Live
·
Apr 02

Baiyunshan Pharmaceutical Division Secures NMPA Approval for Calcitriol Soft Capsules

Stock News
·
Apr 01

Baiyunshan Pharma Reports No Changes to Share Capital in March 2026 Monthly Return

Bulletin Express
·
Apr 01

Domestic ED Drug Jinge's Sales Decline for Second Consecutive Year

Deep News
·
Mar 27

Baiyunshan Pharmaceutical Announces RMB0.45 Final Dividend for FY2025

Bulletin Express
·
Mar 20

BAIYUNSHAN PH (00874) Announces Final Dividend of HK$0.45 Per Share

Stock News
·
Mar 20

BAIYUNSHAN PH Reports Annual Results with 5.21% Increase in Net Profit

Stock News
·
Mar 20

GPC and Baiyunshan Launch Phase One of Financial Transformation Initiative

Deep News
·
Mar 17

Baiyunshan Pharma's Subsidiary Gets Nod for Xu Han Ting Granules' Trial As Respiratory Treatment

MT Newswires Live
·
Mar 17

Hong Kong Market Announcements: Ant Group's Acquisition of Bright Smart Receives Approval, Trading Resumes March 17

Stock News
·
Mar 17

Clinical Trial Application for Baiyunshan's Xuhanting Granules in Pediatric Recurrent Respiratory Infections Receives Approval

Stock News
·
Mar 16

Baiyunshan Receives SSE Approval for Guangzhou Pharmaceutical Receivables ABS Listing

Stock News
·
Mar 16

Baiyunshan Pharmaceutical (00874) Sets 20 Mar 2026 Board Meeting to Approve FY2025 Audited Results

Bulletin Express
·
Mar 10

JPMorgan Reduces Stake in BAIYUNSHAN PH, Selling 207,200 Shares at HK$18.75 Each

Deep News
·
Mar 09